Pelagatti MA, Cazzaniga R, Rogari P, Zanetto F, Buzzetti R. Due sole dosi di anti-meningococco nei primi mesi di vita?. Ricerca e Pratica, 2017;33(4):178-180
Pelagatti MA, Cazzaniga R, Rogari P, Zanetto F, Buzzetti R. Due sole dosi di anti-meningococco nei primi mesi di vita?. Ricerca e Pratica, 2017;33(4):178-180
Buzzetti R, Callegari M, Signorini R, Doria M. Linee guida della Regione Emilia-Romagna sulla Faringotonsillite acuta e sull’ Otite Media Acuta in età pediatrica. Dossier n. 253/2015 e n. 254/2015.. Quaderni ACP - Pagine elettroniche, 2017;24(1):1-4
Buzzetti R, Salvatore D.. Combining Clinical Trial and Patient Registry Data in Cystic Fibrosis: Who Should Be Compared?. Am J Respir Crit Care Med., 2017;Feb 1;195(3):404-405
Pontrelli G, De Crescenzo F, Buzzetti R, Jenkner A, Balduzzi S, Calò Carducci F, Amodio D, De Luca M, Chiurchiù S, Davies EH, Copponi G, Simonetti A, Ferretti E, Di Franco V, Rasi V, Della Corte M, Gramatica L, Ciabattini M, Livadiotti S, Rossi P.. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis.. BMC Infect Dis. , 2017;Apr 24;17(1):302. doi: 10.1186/s12879-017-2396-7.:-
Cirilli N, Southern KW, Buzzetti R, Barben J, Nährlich L, Munck A, Wilschanski M, De Boeck C, Derichs N, on behalf of the ECFS Diagnostic Network Working Group. Real life practice of sweat testing in Europe. Journal f Cystic Fibrosis, 2017;Sep 27. pii: S1569-1993(17)30881-0. doi: 10.1016/j.jcf.2017.09.002. [Epub ahead of print]:-
Terlizzi V, Cirilli N, Galici V, Neri AS, Baldo E, Dinella G, Guerzoni C, Turrin V, Adami A, Buzzetti R, Braggion C. Are cystic fibrosis guidelines credible? Evaluating methodological issues. J Cyst Fibros, 2017;16 (Suppl 1):S172-
Cirilli N, Raia V, De Gregorio F, Di Pietro M, Tosco A, Salvadori L, Sepe A, Buzzetti R, Mincuci N, Rocco I, Castaldo G, Nardiello P. Intra-individual biological variation in sweat chloride concentrations. J Cyst Fibros, 2017;16 (Suppl 1):S19-
Cresta F, Buzzetti R. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura Sustained eradication of new Pseudomonas aeruginosa - Early childhood risk factors for decreased FEVI. Orizzonti FC, 2017;14(1):29-33
Buzzetti R, Galici V, Cirilli N, Majo F, Graziano L, Costa S, Bonacina S, Carrubba M, Davì G, Gagliano S, Cazzarolli C, Ficili F, Alghisi F, Samaja M, Magazzù G; CF Italian Patient Centered Outcomes Research Working Group (IPaCOR).. Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?. J Cyst Fibros., 2018;mar 15:-
Terlizzi V, Lucarelli M, Salvatore D, Angioni A, Bisogno A, Braggion C, Buzzetti R, Carnovale V, Casciaro R, Castaldo G, Cirilli N, Collura M, Colombo C, Di Lullo AM, Elce A, Lucidi V, Madarena E, Padoan R, Quattrucci S, Raia V, Seia M, Termini L, Zarrilli F.. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.. BMC Pulm Med, 2018;18(1):196-